Massive Bio aims to make JIT site model suitable for all clinical trials: CEO 06-Aug-2019 By Melissa Fassbender Massive Bio is looking to create the world’s largest AI-enabled ‘just-in-time’ oncology site network to accelerate study recruitment – and believes that 15-20% of advanced-stage cancer patients can be enrolled in clinical trials, says CEO.